| P50 | author | Jennifer A Doherty | Q57018886 |
| | Joellen M Schildkraut | Q61822968 |
| | Mary Anne Rossing | Q76867095 |
| | Kara L. Cushing-Haugen | Q110347882 |
| | Andrew Berchuck | Q114258102 |
| P2093 | author name string | Martin Köbel | |
| | Holly R Harris | |
| | Lauren C Peres | |
| P2860 | cites work | Origin and molecular pathogenesis of ovarian high-grade serous carcinoma | Q26852698 |
| | An Immunohistochemical Algorithm for Ovarian Carcinoma Typing | Q27313766 |
| | Ovarian cancer epidemiology in the era of collaborative team science | Q30252987 |
| | Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study | Q30428479 |
| | Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data | Q30497053 |
| | Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. | Q30847275 |
| | Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 |
| | Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers | Q34768542 |
| | Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems | Q34998994 |
| | Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer | Q35984294 |
| | The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? | Q36608535 |
| | Recent progress in the diagnosis and treatment of ovarian cancer | Q36622857 |
| | Ovarian cancer: a focus on management of recurrent disease | Q36642130 |
| | Treatment issues in clear cell carcinoma of the ovary: a different entity? | Q36655766 |
| | Characteristics of 10-year survivors of high-grade serous ovarian carcinoma | Q36834937 |
| | Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study | Q36912591 |
| | Histologic subtypes of ovarian carcinoma: an overview. | Q37101055 |
| | Latest research and treatment of advanced-stage epithelial ovarian cancer | Q37206348 |
| | Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. | Q37252742 |
| | Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study | Q37761017 |
| | Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer | Q37777632 |
| | Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis | Q37895891 |
| | Carcinosarcoma of the ovary: a review of the literature | Q37966609 |
| | Ovarian carcinoma diagnosis: the clinical impact of 15 years of change | Q38378337 |
| | Recent trends in ovarian cancer incidence and relative survival in the U.S. by race/ethnicity and histologic subtypes. | Q38656570 |
| | Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary | Q38997509 |
| | Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. | Q40239588 |
| | FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina | Q40718472 |
| | Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary | Q44265152 |
| | Survival among U.S. women with invasive epithelial ovarian cancer | Q46264510 |
| | Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. | Q46792064 |
| | Cancer statistics, 2018. | Q47191906 |
| | Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study | Q47281811 |
| | Who are the long-term survivors of high grade serous ovarian cancer? | Q50059524 |
| | The accuracy of cancer mortality statistics based on death certificates in the United States | Q51786461 |
| | Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. | Q53040744 |
| | Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. | Q53291742 |
| | Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. | Q53306425 |
| | Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease | Q71447496 |
| | Accuracy of cancer death certificates and its effect on cancer mortality statistics | Q71500640 |
| | The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer | Q72644277 |
| | Problems with proper completion and accuracy of the cause-of-death statement | Q73437171 |
| | Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study | Q73923094 |
| | Long-term results and prognostic factors in patients with epithelial ovarian cancer | Q73938099 |
| | Standard cancer patient population for age standardising survival ratios | Q80799769 |
| | Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm | Q83733281 |
| | Natural history and outcome of mucinous carcinoma of the ovary | Q84811431 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 60-68 | |
| P577 | publication date | 2018-04-28 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. | |
| P478 | volume | 111 | |